Gulf Pharmaceutical Industries Overview
- Year Founded
-
1980
- Status
-
Public
- Employees
-
1,968
- Stock Symbol
-
JULPHAR
- Investments
-
4
- Share Price
-
$0.26
- (As of Friday Closing)
Gulf Pharmaceutical Industries General Information
Description
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
Contact Information
Website
www.julphar.netCorporate Office
- PO Box 997 Airport Road
- Digdaga
- Ras Al Khaimah United Arab Emirates
Corporate Office
- PO Box 997 Airport Road
- Digdaga
- Ras Al Khaimah United Arab Emirates
Gulf Pharmaceutical Industries Stock Performance
As of 20-Nov-2026, Gulf Pharmaceutical Industries’s stock price is $0.26. Its current market cap is $296M with 1.16B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.26 | $0.26 | $0.25 - $0.40 | $296M | 1.16B | 1.08M | $0.02 |
Gulf Pharmaceutical Industries Financials Summary
As of 30-Jun-2026, Gulf Pharmaceutical Industries has a trailing 12-month revenue of $300M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 333,425 | 375,967 | 652,204 | 495,609 |
| Revenue | 300,209 | 292,768 | 270,083 | 347,746 |
| EBITDA | 35,444 | 34,326 | 50,630 | 35,333 |
| Net Income | 19,165 | 46,876 | 12,140 | (26,976) |
| Total Assets | 504,505 | 484,497 | 659,989 | 667,946 |
| Total Debt | 74,316 | 74,860 | 264,290 | 302,303 |
Gulf Pharmaceutical Industries Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gulf Pharmaceutical Industries Comparisons
Industry
Financing
Details
Gulf Pharmaceutical Industries Competitors (27)
One of Gulf Pharmaceutical Industries’s 27 competitors is Dr. Reddy's, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India |
Gulf Pharmaceutical Industries Patents
Gulf Pharmaceutical Industries Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20050214365-A1 | Taste, texture; no water required; formulated using pharmaburst (tm) proprietary disintegrant with talc, sodium stearyl fumarate, magnesium stearate and silicon dioxide as lubricants, potassium acesulfate sweetner, anise and mint flavors | Inactive | 24-Mar-2004 | ||
| US-6365198-B1 | Oral composition for amelioration or treatment of gastrointestinal ulcers and hemorrhoids comprising effective amounts of extracts of huanglian, huangqin, huangbo, pheretima, and opuntia | Inactive | 28-Jan-2001 |
Gulf Pharmaceutical Industries Signals
Gulf Pharmaceutical Industries Investments & Acquisitions (4)
Gulf Pharmaceutical Industries’s most recent deal was a Merger/Acquisition with Planet Pharmacies. The deal was made on 13-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Planet Pharmacies | 13-Jan-2022 | Merger/Acquisition | Distributors (Healthcare) | ||
| RAK Pharmaceuticals | 10-Feb-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Julphar Ethiopia | 01-Feb-2013 | Joint Venture | Pharmaceuticals | ||
| Planet Pharmacies | 01-Jan-2007 | Joint Venture | Distributors (Healthcare) |
Gulf Pharmaceutical Industries ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Gulf Pharmaceutical Industries Exits (1)
Gulf Pharmaceutical Industries’s most recent exit was on 01-Feb-2013 from Julphar Ethiopia. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Julphar Ethiopia | 01-Feb-2013 | Completed |
|
Gulf Pharmaceutical Industries Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Planet Pharmacies | Dubai, United Arab Emirates | 2007 |
Gulf Pharmaceutical Industries FAQs
-
When was Gulf Pharmaceutical Industries founded?
Gulf Pharmaceutical Industries was founded in 1980.
-
Where is Gulf Pharmaceutical Industries headquartered?
Gulf Pharmaceutical Industries is headquartered in Ras Al Khaimah, United Arab Emirates.
-
What is the size of Gulf Pharmaceutical Industries?
Gulf Pharmaceutical Industries has 1,968 total employees.
-
What industry is Gulf Pharmaceutical Industries in?
Gulf Pharmaceutical Industries’s primary industry is Pharmaceuticals.
-
Is Gulf Pharmaceutical Industries a private or public company?
Gulf Pharmaceutical Industries is a Public company.
-
What is Gulf Pharmaceutical Industries’s stock symbol?
The ticker symbol for Gulf Pharmaceutical Industries is JULPHAR.
-
What is the current stock price of Gulf Pharmaceutical Industries?
As of 20-Nov-2026 the stock price of Gulf Pharmaceutical Industries is $0.26.
-
What is the current market cap of Gulf Pharmaceutical Industries?
The current market capitalization of Gulf Pharmaceutical Industries is $296M.
-
What is Gulf Pharmaceutical Industries’s current revenue?
The trailing twelve month revenue for Gulf Pharmaceutical Industries is $300M.
-
Who are Gulf Pharmaceutical Industries’s competitors?
Dr. Reddy's, Sun Pharmaceutical Industries, Evonile Pharma, Cipla, and Torrent Pharmaceuticals are some of the 27 competitors of Gulf Pharmaceutical Industries.
-
What is Gulf Pharmaceutical Industries’s annual earnings per share (EPS)?
Gulf Pharmaceutical Industries’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process